A detailed history of Gamma Investing LLC transactions in Csl LTD stock. As of the latest transaction made, Gamma Investing LLC holds 2,205 shares of CSLLY stock, worth $190,820. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,205
Previous 1,802 22.36%
Holding current value
$190,820
Previous $177 Million 22.72%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$97.0 - $105.54 $39,091 - $42,532
403 Added 22.36%
2,205 $218 Million
Q2 2024

Jul 02, 2024

BUY
$86.82 - $98.5 $13,022 - $14,775
150 Added 9.08%
1,802 $177 Million
Q1 2024

Apr 05, 2024

SELL
$89.91 - $99.41 $8,811 - $9,742
-98 Reduced 5.6%
1,652 $156 Million
Q4 2023

Feb 01, 2024

BUY
$73.1 - $97.93 $127,924 - $171,377
1,750 New
1,750 $172 Million

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $83.5B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.